
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
David Amsellem Downgraded (TEVA) to Sell on, Feb 9th, 2018


🞛 This publication is a summary or evaluation of another publication
David Amsellem of Piper Sandler, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Sell on, Feb 9th, 2018.
David has made no other calls on TEVA in the last 4 months.
There are 10 other peers that have a rating on TEVA. Out of the 10 peers that are also analyzing TEVA, 5 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Tim Chiang of "BTIG" Downgraded from Strong Buy to Hold on, Thursday, January 18th, 2018
- Vamil Divan of "Credit Suisse" Upgraded from Sell to Hold on, Friday, December 15th, 2017
- David Risinger of "Morgan Stanley" Upgraded from Sell to Hold on, Friday, December 15th, 2017
- Rohit Vanjani of "Guggenheim" Initiated at Hold and Held Target at $16 on, Tuesday, December 12th, 2017
- Douglas Tsao of "Barclays" Maintained at Hold with Decreased Target to $19 on, Friday, October 20th, 2017
These are the ratings of the 5 analyists that currently disagree with David
- Irina Rivkind Koffler of "Mizuho" Upgraded from Hold to Strong Buy on, Tuesday, January 9th, 2018
- Jacob Hughes of "Wells Fargo" Downgraded from Hold to Sell on, Friday, January 5th, 2018
- Liav Abraham of "Citigroup" Upgraded from Hold to Strong Buy on, Thursday, January 4th, 2018
- Jami Rubin of "Goldman Sachs" Upgraded from Hold to Strong Buy on, Friday, December 15th, 2017
- Chris Schott of "JP Morgan" Downgraded from Hold to Sell on, Monday, November 13th, 2017
Similar Stocks and Investing Publications
[ Thu, Jan 18th 2018 ]: WOPRAI
[ Tue, Jan 09th 2018 ]: WOPRAI
[ Fri, Jan 05th 2018 ]: WOPRAI
[ Thu, Jan 04th 2018 ]: WOPRAI
[ Tue, Jan 02nd 2018 ]: WOPRAI
[ Fri, Dec 15th 2017 ]: WOPRAI
[ Fri, Dec 15th 2017 ]: WOPRAI
[ Fri, Dec 15th 2017 ]: WOPRAI
[ Tue, Dec 12th 2017 ]: WOPRAI
[ Mon, Nov 13th 2017 ]: WOPRAI
[ Tue, Feb 28th 2017 ]: WOPRAI
[ Fri, Feb 10th 2017 ]: WOPRAI